Transient versus permanent congenital hypothyroidism after the age of 3 years in infants detected on the first versus second newborn screening test in Oregon, USA

George A. Ford, Sara Denniston, David Sesser, Michael R. Skeels, Stephen Lafranchi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background/Aims: The newborn screening (NBS) program in Oregon, USA, collects two routine specimens in all infants. The aim of our study was to determine the incidence of permanent versus transient congenital hypothyroidism (CH) in infants detected on the first versus second screening test. Methods: Thyroid function was determined in infants after the age of 3 years diagnosed with CH and born in Oregon between 2005 and 2011. Permanent hypothyroidism was defined as a TSH rise >10 mIU/ml after the first year on treatment or a TSH rise >6 mIU/ml with temporary discontinuation of l-thyroxine after the age of 3 years. Results: Of the cases detected on the first test, 72 of 87 (83%) were permanent and 15 of 87 (17%) were transient, while of the cases detected on the second test, 5 of 22 (23%) were permanent and 17 of 22 (77%) were transient (OR 16.3, p < 0.001). There was a female preponderance detected on the first screen versus a male preponderance on the second screen. Blood spot and serum thyroid function tests at diagnosis, before treatment, were not meaningfully different between the two groups. The mean l-thyroxine dose at the age of 3 years was greater on the first screen: 61.2 versus 36.6 μg/day. Conclusions: Infants detected on the second NBS specimen have a higher incidence of transient CH.

Original languageEnglish (US)
Pages (from-to)169-177
Number of pages9
JournalHormone Research in Paediatrics
Volume86
Issue number3
DOIs
StatePublished - Oct 1 2016

Fingerprint

Congenital Hypothyroidism
Newborn Infant
Thyroxine
Thyroid Function Tests
Incidence
Hypothyroidism
Thyroid Gland
Therapeutics
Serum

Keywords

  • Congenital hypothyroidism
  • Newborn screening
  • Second routine screening
  • Transient vs. permanent congenital hypothyroidism

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Transient versus permanent congenital hypothyroidism after the age of 3 years in infants detected on the first versus second newborn screening test in Oregon, USA. / Ford, George A.; Denniston, Sara; Sesser, David; Skeels, Michael R.; Lafranchi, Stephen.

In: Hormone Research in Paediatrics, Vol. 86, No. 3, 01.10.2016, p. 169-177.

Research output: Contribution to journalArticle

Ford, George A. ; Denniston, Sara ; Sesser, David ; Skeels, Michael R. ; Lafranchi, Stephen. / Transient versus permanent congenital hypothyroidism after the age of 3 years in infants detected on the first versus second newborn screening test in Oregon, USA. In: Hormone Research in Paediatrics. 2016 ; Vol. 86, No. 3. pp. 169-177.
@article{232e1f081bcc4b69b3df24b24fe1abe9,
title = "Transient versus permanent congenital hypothyroidism after the age of 3 years in infants detected on the first versus second newborn screening test in Oregon, USA",
abstract = "Background/Aims: The newborn screening (NBS) program in Oregon, USA, collects two routine specimens in all infants. The aim of our study was to determine the incidence of permanent versus transient congenital hypothyroidism (CH) in infants detected on the first versus second screening test. Methods: Thyroid function was determined in infants after the age of 3 years diagnosed with CH and born in Oregon between 2005 and 2011. Permanent hypothyroidism was defined as a TSH rise >10 mIU/ml after the first year on treatment or a TSH rise >6 mIU/ml with temporary discontinuation of l-thyroxine after the age of 3 years. Results: Of the cases detected on the first test, 72 of 87 (83{\%}) were permanent and 15 of 87 (17{\%}) were transient, while of the cases detected on the second test, 5 of 22 (23{\%}) were permanent and 17 of 22 (77{\%}) were transient (OR 16.3, p < 0.001). There was a female preponderance detected on the first screen versus a male preponderance on the second screen. Blood spot and serum thyroid function tests at diagnosis, before treatment, were not meaningfully different between the two groups. The mean l-thyroxine dose at the age of 3 years was greater on the first screen: 61.2 versus 36.6 μg/day. Conclusions: Infants detected on the second NBS specimen have a higher incidence of transient CH.",
keywords = "Congenital hypothyroidism, Newborn screening, Second routine screening, Transient vs. permanent congenital hypothyroidism",
author = "Ford, {George A.} and Sara Denniston and David Sesser and Skeels, {Michael R.} and Stephen Lafranchi",
year = "2016",
month = "10",
day = "1",
doi = "10.1159/000448658",
language = "English (US)",
volume = "86",
pages = "169--177",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Transient versus permanent congenital hypothyroidism after the age of 3 years in infants detected on the first versus second newborn screening test in Oregon, USA

AU - Ford, George A.

AU - Denniston, Sara

AU - Sesser, David

AU - Skeels, Michael R.

AU - Lafranchi, Stephen

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background/Aims: The newborn screening (NBS) program in Oregon, USA, collects two routine specimens in all infants. The aim of our study was to determine the incidence of permanent versus transient congenital hypothyroidism (CH) in infants detected on the first versus second screening test. Methods: Thyroid function was determined in infants after the age of 3 years diagnosed with CH and born in Oregon between 2005 and 2011. Permanent hypothyroidism was defined as a TSH rise >10 mIU/ml after the first year on treatment or a TSH rise >6 mIU/ml with temporary discontinuation of l-thyroxine after the age of 3 years. Results: Of the cases detected on the first test, 72 of 87 (83%) were permanent and 15 of 87 (17%) were transient, while of the cases detected on the second test, 5 of 22 (23%) were permanent and 17 of 22 (77%) were transient (OR 16.3, p < 0.001). There was a female preponderance detected on the first screen versus a male preponderance on the second screen. Blood spot and serum thyroid function tests at diagnosis, before treatment, were not meaningfully different between the two groups. The mean l-thyroxine dose at the age of 3 years was greater on the first screen: 61.2 versus 36.6 μg/day. Conclusions: Infants detected on the second NBS specimen have a higher incidence of transient CH.

AB - Background/Aims: The newborn screening (NBS) program in Oregon, USA, collects two routine specimens in all infants. The aim of our study was to determine the incidence of permanent versus transient congenital hypothyroidism (CH) in infants detected on the first versus second screening test. Methods: Thyroid function was determined in infants after the age of 3 years diagnosed with CH and born in Oregon between 2005 and 2011. Permanent hypothyroidism was defined as a TSH rise >10 mIU/ml after the first year on treatment or a TSH rise >6 mIU/ml with temporary discontinuation of l-thyroxine after the age of 3 years. Results: Of the cases detected on the first test, 72 of 87 (83%) were permanent and 15 of 87 (17%) were transient, while of the cases detected on the second test, 5 of 22 (23%) were permanent and 17 of 22 (77%) were transient (OR 16.3, p < 0.001). There was a female preponderance detected on the first screen versus a male preponderance on the second screen. Blood spot and serum thyroid function tests at diagnosis, before treatment, were not meaningfully different between the two groups. The mean l-thyroxine dose at the age of 3 years was greater on the first screen: 61.2 versus 36.6 μg/day. Conclusions: Infants detected on the second NBS specimen have a higher incidence of transient CH.

KW - Congenital hypothyroidism

KW - Newborn screening

KW - Second routine screening

KW - Transient vs. permanent congenital hypothyroidism

UR - http://www.scopus.com/inward/record.url?scp=84986538577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986538577&partnerID=8YFLogxK

U2 - 10.1159/000448658

DO - 10.1159/000448658

M3 - Article

VL - 86

SP - 169

EP - 177

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 3

ER -